Application 088327
- Type
- ANDA
- Sponsor
- HOSPIRA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 2% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | LIDOCAINE HYDROCHLORIDE | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A088327-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A088327-001 | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | 2% | INJECTABLE / INJECTION | AP | 1984-07-31 | cb3db0bc1861… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A088327-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A088327-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A088327-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A088327-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A088327-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A088327-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A088327-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A088327-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A088327-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A088327-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A088327-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A088327-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A088327-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A088327-001 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A088327-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A088327-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A088327-001 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A088327-001 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A088327-001 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A088327-001 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A088327-001 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A088327-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A088327-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A088327-001 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A088327-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A088327-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A088327-001 | AP | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A088327-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A088327-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A088327-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A088327-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A088327-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A088327-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A088327-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A088327-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A088327-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A088327-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A088327-001 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A088327-001 | AP | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A088327-001 | AP | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 3b2dd84e-cee8-4e58-d494-395a65a353a0 | 2026-01-16 | Warnings, Adverse reactions | 088327 ANDA088327 0409-4277 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 42d9e4cf-ca73-ec6d-e063-6394a90ae937 | 2025-12-18 | Warnings, Adverse reactions | 088327 ANDA088327 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Henry Schein, Inc. | bb53bb10-bb36-4c9b-b632-71455615f9f3 | 2025-09-29 | Warnings, Adverse reactions | 088327 ANDA088327 0404-9895 |
| 1% LIDOCAINE HCI | 1% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 999b1c7b-3495-926a-e053-2a95a90ab206 | 2025-01-08 | Warnings, Adverse reactions | 088327 ANDA088327 51662-1467 |
| 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 78d8fb0a-bfae-6599-e053-2991aa0a2e03 | 2024-01-28 | Warnings, Adverse reactions | 088327 ANDA088327 51662-1326 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 8968c61e-2686-0fe6-e053-2a95a90a15fa | 2023-05-23 | Warnings, Adverse reactions | 088327 ANDA088327 71872-7125 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 858f3faa-e56e-51f9-e053-2a91aa0aa721 | 2023-05-23 | Warnings, Adverse reactions | 088327 ANDA088327 71872-7095 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0404-9895 | Lidocaine Hydrochloride | Lidocaine Hydrochloride Anhydrous | Henry Schein, Inc. | ANDA | Current |
| 0404-9895 | Lidocaine Hydrochloride | Lidocaine Hydrochloride Anhydrous | Henry Schein, Inc. | ANDA | Current |
| 0409-4277 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-4277 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-4277 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-4277 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-4277 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-4277 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-4277 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-4277 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-4277 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-4277 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-4277 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-4277 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-4277 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 51662-1326 | 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1326 | 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1326 | 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1326 | 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1326 | 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1467 | 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1467 | 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 52584-277 | Lidocaine Hydrochloride | Lidocaine Hydrochloride Anhydrous | General Injectables & Vaccines, Inc | ANDA | Current |
| 52584-277 | Lidocaine Hydrochloride | Lidocaine Hydrochloride Anhydrous | General Injectables & Vaccines, Inc | ANDA | Current |
| 52584-277 | Lidocaine Hydrochloride | Lidocaine Hydrochloride Anhydrous | General Injectables & Vaccines, Inc | ANDA | Current |
| 52584-277 | Lidocaine Hydrochloride | Lidocaine Hydrochloride Anhydrous | General Injectables & Vaccines, Inc | ANDA | Current |
| 52584-277 | Lidocaine Hydrochloride | Lidocaine Hydrochloride Anhydrous | General Injectables & Vaccines, Inc | ANDA | Current |
| 52584-277 | Lidocaine Hydrochloride | Lidocaine Hydrochloride Anhydrous | General Injectables & Vaccines, Inc | ANDA | Current |
| 55154-2373 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Cardinal Health | ANDA | Current |
| 55154-6969 | Lidocaine Hydrochloride | lidocaine hydrochloride | Cardinal Health | ANDA | Current |
| 55154-6992 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Cardinal Health | ANDA | Current |
| 61699-4277 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | US MedSource, LLC | ANDA | Current |
| 63739-470 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | McKesson Corporation dba SKY Packaging | ANDA | Current |
| 63739-470 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | McKesson Corporation | ANDA | Current |
| 70529-002 | Lidenzal 2% | LIDOCAINE HYDROCHLORIDE | IT3 Medical LLC | ANDA | Current |
| 70529-002 | Lidenzal 2% | LIDOCAINE HYDROCHLORIDE | IT3 Medical LLC | ANDA | Current |
| 70529-002 | Lidenzal 2% | LIDOCAINE HYDROCHLORIDE | IT3 Medical LLC | ANDA | Current |
| 70529-016 | Fossaoprin SPG2 | Lidocaine hydrochloride, Bupivacaine hydrochloride | IT3 Medical LLC | ANDA | Current |
| 70529-016 | Fossaoprin SPG2 | Lidocaine hydrochloride, Bupivacaine hydrochloride | IT3 Medical LLC | ANDA | Current |
| 70529-016 | Fossaoprin SPG2 | Lidocaine hydrochloride, Bupivacaine hydrochloride | IT3 Medical LLC | ANDA | Current |
| 70529-051 | H-Paxin | Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Betamethasone Sodium Phosphate and Betamethasone Acetate | IT3 Medical LLC | ANDA | Current |
| 70529-051 | H-Paxin | Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Betamethasone Sodium Phosphate and Betamethasone Acetate | IT3 Medical LLC | ANDA | Current |
| 70529-051 | H-Paxin | Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Betamethasone Sodium Phosphate and Betamethasone Acetate | IT3 Medical LLC | ANDA | Current |
| 70529-124 | Prelidopine Pre-Operative System | LIDOCAINE HYDROCHLORIDE | IT3 Medical LLC | ANDA | Current |
| 70529-124 | Prelidopine Pre-Operative System | LIDOCAINE HYDROCHLORIDE | IT3 Medical LLC | ANDA | Current |
| 70529-124 | Prelidopine Pre-Operative System | LIDOCAINE HYDROCHLORIDE | IT3 Medical LLC | ANDA | Current |
| 71872-7095 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | ANDA | Current |
| 71872-7125 | Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | ANDA | Current |